Sidoti downgraded shares of USANA Health Sciences (NYSE:USNA – Free Report) from a strong-buy rating to a hold rating in a report released on Tuesday,Zacks.com reports.
Several other equities analysts have also recently weighed in on USNA. StockNews.com cut shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th. DA Davidson increased their price target on shares of USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a research report on Thursday, January 2nd.
Check Out Our Latest Stock Report on USANA Health Sciences
USANA Health Sciences Stock Performance
Institutional Trading of USANA Health Sciences
Several hedge funds have recently bought and sold shares of the stock. R Squared Ltd purchased a new position in shares of USANA Health Sciences during the 4th quarter valued at about $28,000. Safe Harbor Fiduciary LLC bought a new stake in USANA Health Sciences during the 3rd quarter worth approximately $30,000. KBC Group NV lifted its holdings in USANA Health Sciences by 96.6% during the third quarter. KBC Group NV now owns 1,056 shares of the company’s stock valued at $40,000 after purchasing an additional 519 shares in the last quarter. KLP Kapitalforvaltning AS purchased a new position in USANA Health Sciences during the fourth quarter valued at approximately $83,000. Finally, Quantbot Technologies LP bought a new position in shares of USANA Health Sciences in the fourth quarter worth approximately $132,000. Institutional investors own 54.25% of the company’s stock.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Recommended Stories
- Five stocks we like better than USANA Health Sciences
- The Role Economic Reports Play in a Successful Investment Strategy
- 3 Beauty Stocks Off to an Ugly Start—Can 1 Stage a Comeback?
- Insider Trades May Not Tell You What You Think
- Fastenal : Growth Trends, Challenges & Key Investment Insights
- What is a Bond Market Holiday? How to Invest and Trade
- 2 Auto Stocks to Let Go and 1 Worth Buying for the Long Haul
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.